Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Bayer claims naphthyridine derivatives

Sep. 27, 1996

Generic cefaclor approved in the U.S.

Sep. 27, 1996

Takeda develops new pediatric formulation of Firstcin

Sep. 27, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Sixteenth approval for Amphotec

Sep. 20, 1996

New topical triazole antifungal agent from Kaken

Sep. 20, 1996

Optically active triazole antifungal agent from Takeda

Sep. 20, 1996

Antifungal cyclohexapeptides from Merck & Co.

Sep. 20, 1996

Safe, broad-spectrum quinolones from Wakunaga

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...